| [1] |
WEI Feng, HE Yang, FAN Zhiqiang, LIU Shikun, OUYANG Linqi.
Inhibitory effect of flufenidone on TGF-β1/Smads pathway in hepatocytes of rats with diethylnitrosamine (DEN)-induced liver injury
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(7): 739-746.
|
| [2] |
LIN Xueyan, LIN Zhihui, HUANG Huping.
Effect of terlipressin on renal function in cirrhotic patients with esophageal gastric varices bleeding and normal baseline renal function
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(7): 775-784.
|
| [3] |
CHEN Sen, FAN Chang, ZHANG Jiafu, MA Yanzhen, JIANG Hui.
The mechanism of Shugan Jianpi Formula regulating TLR4/MyD88/NLRP3 signaling axis to inhibit pyroptosis in mice with liver fibrosis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(10): 1081-1089.
|
| [4] |
ZHENG Qiongna, WU Qiaoqiao, MA Zhele, ZHANG Xianfei, GAN Fangmin, KONG Qingming.
Interventional effect of low molecular weight heparin on mice with experimental hepatic fibrosis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(5): 511-516.
|
| [5] |
YANG Bo, SHI Dawei, ZHENG Zaoqian.
Pharmaceutical care on one case of hypobrinogenemia induced by hemocoagulase
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(8): 932-936.
|
| [6] |
YUAN Gang, HU Airong, HU Yaoren, ZENG Chuanli, ZHU Dedong, SHI Xiaojun.
Clinical efficacy and long-term prognosis of entecavir and adefovir dipivoxil in the treatment of compensatory hepatitis B cirrhosis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(2): 170-174.
|
| [7] |
ZHAO Pengcheng, ZHANG Chao.
Effects of propofol combined with sevoflurane on kidney function and immune function in patients with cirrhosis after splenectomy
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(11): 1276-1281.
|
| [8] |
HUO Na, LU Haiying, WANG Guiqiang, HUANG Mingjie, WU Chihong, LIN Xiaohong.
Effects of nucleos(t)ide analogues on renal function in patients with chronic hepatitis B
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(9): 1029-1034.
|
| [9] |
HUA Xiao-ping, ZHANG Li, HUANG Li, TAN Zheng-huai, CHEN Zhuang.
Morphological differences of liver between two liver fibrosis models induced by dimethylnitrosamine and thioacetamide
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2014, 19(7): 747-751.
|
| [10] |
LI Dong, XIA Chen-mei, CHEN Xia, YAN Hai-fan, FENG Chong-zhi.
Effects of calcitriol on bone mineral density and bone metabolic markers in male patients with alcoholic cirrhosis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2014, 19(6): 691-694.
|
| [11] |
YE Lei, LI Jian-shuang, CHEN Zhi-yun, YAN Mao-xiang, HE Pei-hui.
The role of ginkgo biloba extract on the hepatic GRP78 and CHOP expression in rats with liver fibrosis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2014, 19(4): 377-380.
|
| [12] |
ZHUANG Rang-xiao, WANG Fu-gen, SHAO Yi-dan, FANG Hong-ying, SUN Jing-jing, XI Jian-jun, PAN Jin-ming, LIANG Wei-feng, LIU Shou-rong.
Experimental study of acetylcysteine magnesium-glycyrrhizin fine antipode dimers on rat liver fibrosis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2014, 19(12): 1337-1341.
|
| [13] |
FU Ling-zhu, ZHENG Ting, ZHANG Yong-sheng.
Advances in understanding the role of TGF-β/Smad signalling pathways in the pathogenesis of liver fibrosis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2014, 19(10): 1189-1195.
|
| [14] |
ZHU Yan-hong, CHEN Zhen, QIAN Zhi-yu, HU Hui, CHENG Wen-yuan.
Effects of crocetin on proliferation and collagen synthesis of hepatic stellate cell
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2013, 18(8): 841-846.
|
| [15] |
CHENG Zhi-yun, PENG Jun-chun, LV Ying-hui.
Role of epithelial-mesenchymal transition in the liver fibrosis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2013, 18(8): 928-936.
|
